Midterm Outcomes of Endovascular Repair of Aortic Arch Aneurysms with the Gore Thoracic Branch Endoprosthesis.


Journal

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
ISSN: 1532-2165
Titre abrégé: Eur J Vasc Endovasc Surg
Pays: England
ID NLM: 9512728

Informations de publication

Date de publication:
12 2022
Historique:
received: 23 08 2021
revised: 17 07 2022
accepted: 05 08 2022
pubmed: 16 8 2022
medline: 20 12 2022
entrez: 15 8 2022
Statut: ppublish

Résumé

Aortic aneurysms involving aortic arch vessels are anatomically unsuitable for standard thoracic endovascular repair (TEVAR) without cervical debranching of the arch vessels. Three year outcomes of a single branched thoracic endograft following previous publication of peri-operative and one year outcomes are reported. This was a multicentre feasibility trial of the GORE TAG Thoracic Branch Endoprosthesis (TBE), a thoracic endovascular graft incorporating a single retrograde branch for aortic arch vessel perfusion. The first study arm enrolled patients with an intact descending thoracic aortic aneurysm extending to the distal arch with left subclavian artery (LSA) incorporation (zone 2). The second arm enrolled patients with arch aneurysms requiring incorporation of the left carotid or innominate artery (zone 0/1) and extra-anatomic surgical revascularisation of the remaining aortic arch vessels. Outcomes at three years are reported. The cohort comprised 40 patients (31 zone 2, nine zone 0/1). The majority were male (52%). Mean follow up was 1 408 ± 552 days in the zone 2 and 1 187 ± 766 days in the zone 0/1 cohort. During three year follow up there was no device migration, fracture, or aortic rupture in either arm. In the zone 2 arm, freedom from re-intervention was 97% at one and three years but there were two side branch occlusions. Two patients had aneurysm enlargement > 5 mm without documented endoleak or re-intervention. Freedom from death at one and three years was 90% and 84%. In the zone 0/1 arm there were no re-interventions, loss of branch patency, or aneurysm enlargement at three years. Cerebrovascular events occurred in three patients during follow up: two unrelated to the device or procedure, and one of unknown relationship. Two patients in this arm died during the follow up period, both unrelated to the procedure or the aneurysm. Initial three year results of the TBE device for endovascular repair of arch aneurysms show favourable patency and durability with low rates of graft related complications.

Identifiants

pubmed: 35970335
pii: S1078-5884(22)00506-8
doi: 10.1016/j.ejvs.2022.08.003
pii:
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

639-645

Informations de copyright

Copyright © 2022 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.

Auteurs

Nathan L Liang (NL)

Division of Vascular Surgery, University of Pittsburgh Medical Centre, Pittsburgh, PA, USA. Electronic address: liangnl@upmc.edu.

Michael D Dake (MD)

Department of Medical Imaging, University of Arizona Health System, Tucson, AZ, USA.

Michael P Fischbein (MP)

Department of Cardiothoracic Surgery, Stanford University Hospitals, Palo Alto, CA, USA.

Joseph E Bavaria (JE)

Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.

Nimesh D Desai (ND)

Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.

Gustavo S Oderich (GS)

Department of Cardiothoracic and Vascular Surgery, The University of Texas Health Science Centre at Houston, McGovern Medical School, Houston, TX, USA.

Michael J Singh (MJ)

Division of Vascular Surgery, University of Pittsburgh Medical Centre, Pittsburgh, PA, USA.

Mark Fillinger (M)

Section of Vascular of Surgery, Dartmouth-Hitchcock Medical Centre, Lebanon, NH, USA.

Bjoern D Suckow (BD)

Section of Vascular of Surgery, Dartmouth-Hitchcock Medical Centre, Lebanon, NH, USA.

Jon S Matsumura (JS)

Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison WI, USA.

Himanshu J Patel (HJ)

Department of Cardiac Surgery, University of Michigan Frankel Cardiovascular Centre, Ann Arbor, MI, USA.

Michel S Makaroun (MS)

Division of Vascular Surgery, University of Pittsburgh Medical Centre, Pittsburgh, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH